IT1173725B - Composizione terapeutica a base di acido 5-idrossi-decanoico o suoi de rivati,per il trattamento di malattie cardiovascolari - Google Patents

Composizione terapeutica a base di acido 5-idrossi-decanoico o suoi de rivati,per il trattamento di malattie cardiovascolari

Info

Publication number
IT1173725B
IT1173725B IT48588/83A IT4858883A IT1173725B IT 1173725 B IT1173725 B IT 1173725B IT 48588/83 A IT48588/83 A IT 48588/83A IT 4858883 A IT4858883 A IT 4858883A IT 1173725 B IT1173725 B IT 1173725B
Authority
IT
Italy
Prior art keywords
rivati
hydroxy
treatment
therapeutic composition
cardiovascular diseases
Prior art date
Application number
IT48588/83A
Other languages
English (en)
Other versions
IT8348588A0 (it
Inventor
Haruo Ohnishi
Kazuo Yamaguchi
Yasuo Suzuki
Nobuo Mochida
Original Assignee
Mochida Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mochida Pharm Co Ltd filed Critical Mochida Pharm Co Ltd
Publication of IT8348588A0 publication Critical patent/IT8348588A0/it
Application granted granted Critical
Publication of IT1173725B publication Critical patent/IT1173725B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D315/00—Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups C07D303/00 - C07D313/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IT48588/83A 1982-06-28 1983-06-28 Composizione terapeutica a base di acido 5-idrossi-decanoico o suoi de rivati,per il trattamento di malattie cardiovascolari IT1173725B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57111183A JPS591415A (ja) 1982-06-28 1982-06-28 循環系疾患治療剤

Publications (2)

Publication Number Publication Date
IT8348588A0 IT8348588A0 (it) 1983-06-28
IT1173725B true IT1173725B (it) 1987-06-24

Family

ID=14554592

Family Applications (1)

Application Number Title Priority Date Filing Date
IT48588/83A IT1173725B (it) 1982-06-28 1983-06-28 Composizione terapeutica a base di acido 5-idrossi-decanoico o suoi de rivati,per il trattamento di malattie cardiovascolari

Country Status (11)

Country Link
US (1) US4578400A (it)
JP (1) JPS591415A (it)
AU (1) AU546935B2 (it)
CA (1) CA1209921A (it)
CH (1) CH660556A5 (it)
DE (1) DE3323264C2 (it)
FR (1) FR2529081B1 (it)
GB (1) GB2123691B (it)
IT (1) IT1173725B (it)
NL (1) NL187299C (it)
SE (1) SE462419B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2665737B2 (ja) * 1986-05-27 1997-10-22 宇部興産株式会社 微粒子状無機フイラー分散液の製造法
CA2016467A1 (en) 1989-06-05 1990-12-05 Martin Eisman Method for treating peripheral atherosclerotic disease employing an hmg coa reductase inhibitor and/or a squalene synthetase inhibitor
US5234947A (en) * 1991-11-07 1993-08-10 New York University Potassium channel activating compounds and methods of use thereof
ES2560847T3 (es) * 2002-07-31 2016-02-23 Yves Saint-Laurent Parfums Células madre procedentes de tejido adiposo y células diferenciadas procedentes de estas células
ATE482698T1 (de) * 2003-06-18 2010-10-15 Inst Cardiologie De Montreal M Vermeidung von vorhofflimmern (af) mit der verwendung von statin
DE102004052697A1 (de) * 2004-10-29 2006-05-04 Haehner, Thomas, Dr. Pharmazeutische Zubereitungen zur Behandlung von Folgen des Alkoholmissbrauchs, Hepatitis, Pankreatitis, Alzheimererkrankung, Morbus Parkinson, Diabetes, toxischen Nierenerkrankungen, Reperfusionsschäden, der Arteriosklerose sowie als Antidote gegen Umweltgifte und Medikamentenintoxikation
ES2510494T3 (es) * 2005-03-02 2014-10-21 Merck Sharp & Dohme Corp. Composición para la inhibición de la catepsina K
DE102006019906A1 (de) * 2006-04-28 2007-10-31 Müller-Enoch, Dieter, Prof. Dr. Verwendung von Verbindungen der Formel A-R-X oder deren pharmazeutisch akzeptable Salze zur Herstellung einer pharmazeutischen Zubereitung
WO2013146539A1 (ja) * 2012-03-27 2013-10-03 辻本化学工業株式会社 ＰＰＡＲｓアゴニスト活性亢進薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1417119A (en) * 1972-11-30 1975-12-10 Thiele G H Process for treating bones
US4225501A (en) * 1977-07-25 1980-09-30 Givaudan Corporation 1,4-Epoxy-1,3,3-trimethyl-2-(2-buten-1-ylidene)-cyclohexanes
US4357315A (en) * 1980-08-07 1982-11-02 International Flavors & Fragrances Inc. Use of 1-ethoxy-1-ethanol acetate for augmenting or enhancing the taste of toothpaste

Also Published As

Publication number Publication date
JPH0142246B2 (it) 1989-09-11
FR2529081B1 (fr) 1985-11-15
CA1209921A (en) 1986-08-19
SE8303700D0 (sv) 1983-06-28
NL187299B (nl) 1991-03-18
NL187299C (nl) 1991-08-16
SE8303700L (sv) 1983-12-29
GB2123691B (en) 1985-07-31
JPS591415A (ja) 1984-01-06
GB2123691A (en) 1984-02-08
AU546935B2 (en) 1985-09-26
FR2529081A1 (fr) 1983-12-30
DE3323264A1 (de) 1984-01-05
SE462419B (sv) 1990-06-25
NL8302273A (nl) 1984-01-16
US4578400A (en) 1986-03-25
IT8348588A0 (it) 1983-06-28
DE3323264C2 (de) 1986-03-06
GB8317357D0 (en) 1983-07-27
CH660556A5 (de) 1987-05-15
AU1631583A (en) 1984-01-05

Similar Documents

Publication Publication Date Title
IT1234215B (it) Forma di dosaggio per il trattamento di malattie cardiovascolari
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
IT1173725B (it) Composizione terapeutica a base di acido 5-idrossi-decanoico o suoi de rivati,per il trattamento di malattie cardiovascolari
IT8149118A0 (it) Procedimento per la produzionedi gonadotropina coriale umana
IT8148915A0 (it) Procedimento per la produzione di insulina umana
IT7928170A0 (it) Composizione farmaceutica a base di acido tiazolidin-4-carbossilico per il trattamento di malattie neoplastiche e metodi di preparazione.
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
IT1131856B (it) Composizione farmaceutica per il trattamento di intossicazioni alcooliche
IT1172398B (it) Procedimento per la produzione di 1,2-diclorcetano
IT8319024A0 (it) Composizione medicinale per il trattamento di certe neurovirosi.
IT8222763A0 (it) Procedimento per la preparazione dell'anidride dell'acido n-formil-l-aspartico.
IT7821264A0 (it) Composizione per il trattamento dell'asma.
IT1154276B (it) Composti piridinici per il trattamento di cardiopatie coronariche
IT1101715B (it) Procedimento per la preparazione di acido 2,5-dichetogluconico
IT8149852A0 (it) Procedimento per la produzione dell'ormone adrenocorticotropico umano
IT1164613B (it) Procedimento per la produzione di ditiazol-disolfuri
IT8123083A0 (it) Procedimento per la preparazione di esteri dell'acido 3-acilazo-propionico.
IT8419940A0 (it) Nuovi medicinali per il trattamento di malattie cardiache.
IT1212555B (it) Composizione a base di dobesilato di calcio per il trattamento di malattie cardiache
IT1171888B (it) Procedimento per la produzione di acciaio inossidabile
IT8219330A0 (it) Composto medicinale per il trattamento di malattie di cuore.
IT8423360A0 (it) Procedimento di preparazione dell'acido 3-idrossi-3-metil-glutarico.
IT1157335B (it) Procedimento per la produzione di talampicillina
IT8321614A0 (it) Medicina per il trattamento di affezione neoplastica.
IT1156320B (it) Procedimento per la preparazione dell'acido 1,4-dimetil-pirrol-5-(p-clorobenzoil)-2-acetico